April 7. 2024 — A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure ...
Hypertension
This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics and renal denervation therapy.
-
-
November 20, 2023 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration (FDA) has approved the Symplicity Spyral renal denervation ...
-
November 20, 2023 — A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has been achieved with the recent U.S. Food & Drug Administration (FDA) approvals of ...
-
November 11, 2023 — Results of a randomized trial presented today at the American Heart Association’s Scientific Sessions 2023 (AHA 2023), which compared the effects of high-sodium and low-sodium ...
April 7. 2024 — A single subcutaneous injection of the investigational drug zilebesiran, when added to existing ...
April 07, 2024
April 1, 2024 — Sleeping fewer than seven hours is associated with a higher risk of developing high blood pressure over ...
April 01, 2024
March 27, 2024 — Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved OPSYNVI – ...
March 27, 2024
March 27, 2024 — Merck, known as MSD outside of the United States and Canada, announced that the U.S. Food and Drug ...
March 27, 2024
March 18, 2024 — The Smidt Heart Institute at Cedars-Sinai recently became one of four institutions in the U.S. and the ...
March 18, 2024
February 28, 2024 — New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center indica ...
February 28, 2024
February 27, 2024 — Aria CV, Inc, a developer of medical devices treating pulmonary hypertension, today announced the ...
February 27, 2024
February 14, 2024 — The replacement of regular salt with a salt substitute can reduce incidences of hypertension, or ...
February 14, 2024
January 19, 2024 — Orchestra BioMed, a biomedical company accelerating high-impact technologies to patients through risk ...
January 19, 2024
December 13, 2023 —Infusions of potentially therapeutic cells derived from the heart are safe for people with pulmonary ...
December 13, 2023
December 7, 2023 — Indiana University School of Medicine researchers at the school’s South Bend regional campus, in ...
December 07, 2023
December 4, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular ...
December 04, 2023
November 20, 2023 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and ...
November 20, 2023
November 20, 2023 — A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has ...
November 20, 2023
November 15, 2023 — Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced the first ...
November 15, 2023© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now